Depressive symptoms predict antibody titers after a second dose of the SARS-CoV-2 BNT162b2 vaccine among hospital workers in Japan.

Kaneko, Hiroshi; Tsuboi, Hirohito

Kaneko, Hiroshi; Tsuboi, Hirohito.

Affiliation

Kaneko H; Division of Internal Medicine & Psychosomatic Internal Medicine, Hoshigaoka Maternity Hospital, Nagoya 464-0026, Japan. Electronic address: hkaneko@fujita-hu.ac.jp.
Tsuboi H; Graduate School of Human Nursing, The University of Shiga Prefecture, 2500 Hassaka-cho, Hikone 522-8533, Japan. Electronic address: tohtori17@gmail.com.

Brain Behav Immun ; 107: 414-418, 2023 01.

Article in En | MEDLINE | ID: mdl-36116693

Subject(s)

COVID-19 Vaccines; COVID-19; Depression; Humans; BNT162 Vaccine; COVID-19/prevention & control; COVID-19 Vaccines/immunology; Hospitals; SARS-CoV-2; Depression/immunology; Antibodies, Viral/blood; Japan; Health Personnel

Key words

Antibody response; Anxiety; BNT162b2 mRNA vaccine; COVID-19; Depression; Health care worker; Japan; Psychological factor; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depression / COVID-19 Vaccines / COVID-19 Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Brain Behav Immun Journal subject: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google